The Target: Stroke initiative improved thrombolysis rates, but Black patients had significantly lower odds of receiving thrombolysis than White patients in phase III (aOR 0.76; 95% CI 0.74-0.78).
Cohort (n=1,189,234)
Sí
Does the Target: Stroke quality initiative improve thrombolysis rates and time metrics across different racial and ethnic groups in patients with acute ischemic stroke?
While a nationwide quality initiative improved stroke thrombolysis rates and times overall, significant racial and ethnic disparities persist, with Asian, Black, and Hispanic patients less likely to receive timely treatment compared to White patients.
Estimación del efecto: aOR 0.76 (95% CI 0.74-0.78)
Importance: Understanding is needed of racial and ethnic-specific trends in care quality and outcomes associated with the US nationwide quality initiative Target: Stroke (TS) in targeting thrombolysis treatment for acute ischemic stroke. Objective: To examine whether the TS quality initiative was associated with improvement in thrombolysis metrics and outcomes across racial and ethnic groups. Design, Setting, and Participants: This retrospective cohort study included patients who presented within 4.5 hours of ischemic stroke onset at hospitals participating in the Get With The Guidelines-Stroke initiative from January 1, 2003, to December 31, 2021. The data analysis was performed between December 15, 2022, and November 27, 2023. Exposures: TS phases I (2010-2013), II (2014-2018), and III (2019-2021). Main Outcomes and Measures: The primary outcomes were thrombolysis rates and time metrics. Patient function and mortality were secondary outcomes. Results: Analyses included 1 189 234 patients, of whom 1 053 539 arrived to the hospital within 4.5 hours. The cohort included 50.4% female and 49.6% male patients and 2.8% Asian median (IQR) age, 72 (61-82) years, 15.2% Black median (IQR) age, 64 (54-75) years, 7.3% Hispanic median (IQR) age, 68 (56-79) years, and 74.1% White median (IQR) age, 75 (63-84) years patients). Unadjusted thrombolysis rates increased in both the pre-TS (2003-2009) and TS periods in all racial and ethnic groups from 10% to 15% in 2003 to 43% to 46% in 2021, but disparities were observed in adjusted analyses and persisted in TS phase III, with Asian, Black, and Hispanic patients having significantly lower odds of receiving thrombolysis than White patients (adjusted odds ratio, 0.85 95% CI, 0.81-0.90, 0.76 95% CI, 0.74-0.78, and 0.86 95% CI, 0.83-0.89, respectively). Door-to-needle (DTN) times improved in all racial and ethnic groups during TS, with DTN times of 60 minutes or less increasing from 26% to 28% in 2009 to 66% to 72% in 2021. However, in adjusted analyses, racial and ethnic disparities emerged. During TS phase III, compared with White patients, Asian, Black, and Hispanic patients had significantly lower odds of receiving thrombolysis with a DTN time of 60 minutes or less compared with White patients (risk-adjusted odds ratios, 0.91 95% CI, 0.84-0.98, 0.78 95% CI, 0.75-0.81, and 0.87 95% CI, 0.83-0.92, respectively). During TS, clinical outcomes improved for all racial and ethnic groups from pre-TS, with TS phase III showing higher odds of ambulation at discharge among Asian, Black, Hispanic, and White patients. Asian, Black, and Hispanic patients were less likely to present within 4.5 hours. Conclusions and Relevance: In this cohort study of patients with ischemic stroke, the TS quality initiative was associated with improvement in thrombolysis frequency, timeliness, and outcomes for all racial and ethnic groups. However, disparities persisted, indicating a need for further interventions.
Man et al. (Wed,) conducted a cohort in Acute ischemic stroke (n=1,189,234). Target: Stroke (TS) quality initiative vs. Pre-TS period and White patients was evaluated on Thrombolysis rates and time metrics (aOR 0.76, 95% CI 0.74-0.78). The Target: Stroke initiative improved thrombolysis rates, but Black patients had significantly lower odds of receiving thrombolysis than White patients in phase III (aOR 0.76; 95% CI 0.74-0.78).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: